Vascular Health and Risk Management
Volume 10, 2014 - Issue
Open access
82
Views
23
CrossRef citations to date
0
Altmetric
Study Protocol
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
A John Camm1 Division of Clinical Sciences, St George’s, University of London, London, UKCorrespondence[email protected]
, Pierre Amarenco2 Department of Neurology and Stroke Center, Paris-Diderot-Sorbonne University, Paris, France
, Sylvia Haas3 Vascular Center, Munich, Germany
, Susanne Hess4 Medical Affairs, Bayer HealthCare Pharmaceuticals, Berlin, Germany
, Paulus Kirchhof5 Centre for Cardiovascular Sciences, University of Birmingham and Sandwell & West Birmingham Hospitals NHS Trust, Birmingham, UK;6 Department of Cardiovascular Medicine, University of Münster, Münster, Germany
, Martin van Eickels4 Medical Affairs, Bayer HealthCare Pharmaceuticals, Berlin, Germany
& Alexander GG Turpie7 Department of Medicine, McMaster University, Hamilton, ON, Canada
show all
Pages 425-434
|
Published online: 17 Jul 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.